[
  {
    "ID": 1,
    "Current Date": "06.02.2025",
    "Display in Registry": "Yes",
    "Gene": "ATM",
    "RefSeq Transcript": "NM_000051.4",
    "Coding DNA change (c.)": "c.7865C>T",
    "Predicted protein change (p.)": "p.Ala2622Val",
    "Confirmed protein or RNA change (for splicing variants)": "Partial exon deletion;\r\n\r\nr.7864_7929del, p.Ala2622Lysfs*3",
    "Variant published?": "Yes",
    "Contact Person": "Yu Lab",
    "Institution": "BCH",
    "Contact Information (email)": "Tyuresearch@childrens.harvard.edu",
    "Therapeutic Modality": "Antisense oligonucleotide",
    "Status": "Clinical Application",
    "Approach": "Splice correction",
    "Indication ": "Brain/Spinal cord",
    "IND available?": "Yes",
    "Therapy Publication": "https://pubmed.ncbi.nlm.nih.gov/37438524/",
    "Variant Publication": "https://pubmed.ncbi.nlm.nih.gov/10330348/",
    "Cell Line or Animal Model Availability": "Yes, cell line"
  },
  {
    "ID": 3,
    "Current Date": "06.02.2025",
    "Display in Registry": "Yes",
    "Gene": "ATM",
    "RefSeq Transcript": "NM_000051.4",
    "Coding DNA change (c.)": "c.5763-1050A>G",
    "Predicted protein change (p.)": "p.?",
    "Confirmed protein or RNA change (for splicing variants)": "Pseudoexon activation;\r\n\r\nr.5762_5763ins[137]",
    "Variant published?": "Yes",
    "Contact Person": "Yu Lab",
    "Institution": "BCH",
    "Contact Information (email)": "Tyuresearch@childrens.harvard.edu",
    "Therapeutic Modality": "Antisense oligonucleotide",
    "Status": "Under Development",
    "Approach": "Splice correction",
    "Indication ": "Brain/Spinal cord",
    "IND available?": "No",
    "Variant Publication": "https://pubmed.ncbi.nlm.nih.gov/8755918/",
    "Cell Line or Animal Model Availability": "Yes, cell line"
  },
  {
    "ID": 4,
    "Current Date": "06.02.2025",
    "Display in Registry": "Yes",
    "Gene": "USH2A",
    "RefSeq Transcript": "NM_206933.4",
    "Coding DNA change (c.)": "c.949C>A",
    "Predicted protein change (p.)": "p.Arg317=",
    "Confirmed protein or RNA change (for splicing variants)": "r.951_1143del, p.Tyr318Valfs*9",
    "Variant published?": "Yes",
    "Contact Person": "Yu Lab",
    "Institution": "BCH",
    "Contact Information (email)": "Tyuresearch@childrens.harvard.edu",
    "Therapeutic Modality": "Antisense oligonucleotide",
    "Status": "Under Development",
    "Approach": "Splice correction",
    "Indication ": "Eye",
    "IND available?": "No",
    "Variant Publication": "https://pubmed.ncbi.nlm.nih.gov/34948090/",
    "Cell Line or Animal Model Availability": "No"
  },
  {
    "ID": 5,
    "Current Date": "06.02.2025",
    "Display in Registry": "Yes",
    "Gene": "ATP1A3",
    "RefSeq Transcript": "NM_152296.5",
    "Coding DNA change (c.)": "c.2443G>A",
    "Predicted protein change (p.)": "p.Glu815Lys",
    "Variant published?": "Yes",
    "Contact Person": "Yu Lab",
    "Institution": "BCH",
    "Contact Information (email)": "Tyuresearch@childrens.harvard.edu",
    "Therapeutic Modality": "Antisense oligonucleotide",
    "Status": "Under Development",
    "Approach": "Knockdown",
    "Indication ": "Brain/Spinal cord",
    "IND available?": "No",
    "Variant Publication": "https://pubmed.ncbi.nlm.nih.gov/22842232/",
    "Cell Line or Animal Model Availability": "Yes, cell line"
  },
  {
    "ID": 6,
    "Current Date": "06.02.2025",
    "Display in Registry": "Yes",
    "Gene": "USH2A",
    "RefSeq Transcript": "NM_206933.4",
    "Coding DNA change (c.)": "c.7595-2144A>G",
    "Predicted protein change (p.)": "p.?",
    "Confirmed protein or RNA change (for splicing variants)": "Pseudoexon activation;\r\n\r\nr.7594_7595ins[7595-2296_7595-2143]",
    "Variant published?": "Yes",
    "Contact Person": "Yu Lab",
    "Institution": "BCH",
    "Contact Information (email)": "Tyuresearch@childrens.harvard.edu",
    "Therapeutic Modality": "Antisense oligonucleotide",
    "Status": "Under Development",
    "Approach": "Splice correction",
    "Indication ": "Eye",
    "IND available?": "No",
    "Variant Publication": "https://pubmed.ncbi.nlm.nih.gov/22009552/",
    "Cell Line or Animal Model Availability": "Yes, cell line"
  },
  {
    "ID": 7,
    "Current Date": "06.02.2025",
    "Display in Registry": "Yes",
    "Gene": "KCNQ2",
    "RefSeq Transcript": "NM_172107.4",
    "Coding DNA change (c.)": "c.683A>G",
    "Predicted protein change (p.)": "p.His228Arg",
    "Variant published?": "Yes",
    "Contact Person": "Yu Lab",
    "Institution": "BCH",
    "Contact Information (email)": "Tyuresearch@childrens.harvard.edu",
    "Therapeutic Modality": "Antisense oligonucleotide",
    "Status": "Under Development",
    "Approach": "Knockdown",
    "Indication ": "Brain/Spinal cord",
    "IND available?": "No",
    "Variant Publication": "https://pubmed.ncbi.nlm.nih.gov/31951342/",
    "Cell Line or Animal Model Availability": "Yes, cell line"
  },
  {
    "ID": 8,
    "Current Date": "06.02.2025",
    "Display in Registry": "Yes",
    "Gene": "MFSD8",
    "RefSeq Transcript": "NM_152778.4",
    "Coding DNA change (c.)": "c.291G>C",
    "Predicted protein change (p.)": "p.Trp97Cys",
    "Variant published?": "Yes",
    "Contact Person": "Yu Lab",
    "Institution": "BCH",
    "Contact Information (email)": "Tyuresearch@childrens.harvard.edu",
    "Therapeutic Modality": "Antisense oligonucleotide",
    "Status": "Under Development",
    "Approach": "Splice correction",
    "Indication ": "Brain/Spinal cord",
    "IND available?": "No",
    "Variant Publication": "https://pubmed.ncbi.nlm.nih.gov/28794409/",
    "Cell Line or Animal Model Availability": "Yes, cell line"
  },
  {
    "ID": 9,
    "Current Date": "06.02.2025",
    "Display in Registry": "Yes",
    "Gene": "KCNT1",
    "RefSeq Transcript": "NM_020822.3",
    "Coding DNA change (c.)": "c.1421G>A",
    "Predicted protein change (p.)": "p.Arg474His",
    "Variant published?": "Yes",
    "Contact Person": "Yu Lab",
    "Institution": "BCH",
    "Contact Information (email)": "Tyuresearch@childrens.harvard.edu",
    "Therapeutic Modality": "Antisense oligonucleotide",
    "Status": "Clinical Application",
    "Approach": "Knockdown",
    "Indication ": "Brain/Spinal cord",
    "IND available?": "No",
    "Variant Publication": "https://pubmed.ncbi.nlm.nih.gov/23086397/",
    "Cell Line or Animal Model Availability": "Yes, cell line",
    "Comment": "ASO has shown adverse events in clinical application. Please reach out to the developers for more information."
  },
  {
    "ID": 10,
    "Current Date": "06.02.2025",
    "Display in Registry": "Yes",
    "Gene": "MECP2",
    "RefSeq Transcript": "NM_004992.4",
    "Coding DNA change (c.)": "c.378-3C>G",
    "Predicted protein change (p.)": "p.?",
    "Confirmed protein or RNA change (for splicing variants)": "Intron 3; strengthens new acceptor site 1bp upstream of the variant; weakens canonical splice site 3bp upstream of the variant\r\n\r\nr.?",
    "Variant published?": "Yes",
    "Contact Person": "Yu Lab",
    "Institution": "BCH",
    "Contact Information (email)": "Tyuresearch@childrens.harvard.edu",
    "Therapeutic Modality": "Antisense oligonucleotide",
    "Status": "Under Development",
    "Approach": "Splice correction",
    "Indication ": "Brain/Spinal cord",
    "IND available?": "No",
    "Variant Publication": "https://pubmed.ncbi.nlm.nih.gov/15737703/",
    "Cell Line or Animal Model Availability": "Yes, cell line"
  },
  {
    "ID": 11,
    "Current Date": "04.03.2024",
    "Display in Registry": "Yes",
    "Gene": "ATM",
    "RefSeq Transcript": "NM_000051.4",
    "Coding DNA change (c.)": "c.2839-579_2839-576del",
    "Predicted protein change (p.)": "p.?",
    "Confirmed protein or RNA change (for splicing variants)": "Pseudoexon activation;\r\n\r\nr.2839-579_2839-576delins2839-593_2839-525",
    "Variant published?": "Yes",
    "Contact Person": "Synofzik Lab",
    "Institution": "Tuebingen",
    "Contact Information (email)": "matthis.synofzik@uni-tuebingen.de",
    "Therapeutic Modality": "Antisense oligonucleotide",
    "Status": "Under Development",
    "Approach": "Splice correction",
    "Indication ": "Brain/Spinal cord",
    "IND available?": "No",
    "Variant Publication": "https://pubmed.ncbi.nlm.nih.gov/11889466/",
    "Cell Line or Animal Model Availability": "Yes, cell line"
  },
  {
    "ID": 12,
    "Current Date": "04.03.2024",
    "Display in Registry": "Yes",
    "Gene": "ATM",
    "RefSeq Transcript": "NM_000051.4",
    "Coding DNA change (c.)": "c.2639-384A>G",
    "Predicted protein change (p.)": "p.?",
    "Confirmed protein or RNA change (for splicing variants)": "Pseudoexon activation;\r\n\r\nr.2638_2639ins[2639-442_2639-385], p.Gly880Glufs*14",
    "Variant published?": "Yes",
    "Contact Person": "Synofzik Lab",
    "Institution": "Tuebingen",
    "Contact Information (email)": "matthis.synofzik@uni-tuebingen.de",
    "Therapeutic Modality": "Antisense oligonucleotide",
    "Status": "Under Development",
    "Approach": "Splice correction",
    "Indication ": "Brain/Spinal cord",
    "IND available?": "No",
    "Variant Publication": "https://pubmed.ncbi.nlm.nih.gov/34453918/",
    "Cell Line or Animal Model Availability": "Yes, cell line"
  },
  {
    "ID": 13,
    "Current Date": "04.03.2024",
    "Display in Registry": "Yes",
    "Gene": "ATM",
    "RefSeq Transcript": "NM_000051.4",
    "Coding DNA change (c.)": "c.967A>G",
    "Predicted protein change (p.)": "p.Ile323Val",
    "Confirmed protein or RNA change (for splicing variants)": "Partial and partial + full exon deletions;\r\n\r\nr.967_1235del, p.Ile323Alafs*17\r\nr.967_1065del, p.Ile323_Gln355del",
    "Variant published?": "Yes",
    "Contact Person": "Synofzik Lab",
    "Institution": "Tuebingen",
    "Contact Information (email)": "matthis.synofzik@uni-tuebingen.de",
    "Therapeutic Modality": "Antisense oligonucleotide",
    "Status": "Under Development",
    "Approach": "Splice correction",
    "Indication ": "Brain/Spinal cord",
    "IND available?": "No",
    "Variant Publication": "https://pubmed.ncbi.nlm.nih.gov/31050087/",
    "Cell Line or Animal Model Availability": "Yes, cell line"
  },
  {
    "ID": 14,
    "Current Date": "04.03.2024",
    "Display in Registry": "Yes",
    "Gene": "ATM",
    "RefSeq Transcript": "NM_000051.4",
    "Coding DNA change (c.)": "c.743G>T\r\n",
    "Predicted protein change (p.)": "p.Arg248Leu",
    "Confirmed protein or RNA change (for splicing variants)": "r.?",
    "Variant published?": "Yes",
    "Contact Person": "Synofzik Lab",
    "Institution": "Tuebingen",
    "Contact Information (email)": "matthis.synofzik@uni-tuebingen.de",
    "Therapeutic Modality": "Antisense oligonucleotide",
    "Status": "Under Development",
    "Approach": "Splice correction",
    "Indication ": "Brain/Spinal cord",
    "IND available?": "No",
    "Variant Publication": "https://pubmed.ncbi.nlm.nih.gov/24120321/",
    "Cell Line or Animal Model Availability": "Yes, cell line"
  },
  {
    "ID": 15,
    "Current Date": "04.03.2024",
    "Display in Registry": "Yes",
    "Gene": "ATM",
    "RefSeq Transcript": "NM_000051.4",
    "Coding DNA change (c.)": "c.8565T>G",
    "Predicted protein change (p.)": "p.Ser2855Arg",
    "Confirmed protein or RNA change (for splicing variants)": "r.?",
    "Variant published?": "Yes",
    "Contact Person": "Synofzik Lab",
    "Institution": "Tuebingen",
    "Contact Information (email)": "matthis.synofzik@uni-tuebingen.de",
    "Therapeutic Modality": "Antisense oligonucleotide",
    "Status": "Under Development",
    "Approach": "Splice correction",
    "Indication ": "Brain/Spinal cord",
    "IND available?": "No",
    "Cell Line or Animal Model Availability": "Yes, cell line"
  },
  {
    "ID": 16,
    "Current Date": "04.03.2024",
    "Display in Registry": "Yes",
    "Gene": "ATM",
    "RefSeq Transcript": "NM_000051.4",
    "Coding DNA change (c.)": "c.2250G>A\r\n",
    "Predicted protein change (p.)": "p.Lys750=",
    "Confirmed protein or RNA change (for splicing variants)": "r.2125_2250del, p.Ile709_Lys750del",
    "Variant published?": "Yes",
    "Contact Person": "Synofzik Lab",
    "Institution": "Tuebingen",
    "Contact Information (email)": "matthis.synofzik@uni-tuebingen.de",
    "Therapeutic Modality": "Antisense oligonucleotide",
    "Status": "Under Development",
    "Approach": "Exon inclusion",
    "Indication ": "Brain/Spinal cord",
    "IND available?": "No",
    "Variant Publication": "https://pubmed.ncbi.nlm.nih.gov/9887333/",
    "Cell Line or Animal Model Availability": "Yes, cell line",
    "Comment": "Note: the Yu lab also has some work and cell lines for this variant"
  },
  {
    "ID": 17,
    "Current Date": "04.03.2024",
    "Display in Registry": "Yes",
    "Gene": "ATM",
    "RefSeq Transcript": "NM_000051.4",
    "Coding DNA change (c.)": "c.2376G>A",
    "Predicted protein change (p.)": "p.Lys792=",
    "Confirmed protein or RNA change (for splicing variants)": "r.2251_2376del, p.Ser751_Lys792del",
    "Variant published?": "Yes",
    "Contact Person": "Synofzik Lab",
    "Institution": "Tuebingen",
    "Contact Information (email)": "matthis.synofzik@uni-tuebingen.de",
    "Therapeutic Modality": "Antisense oligonucleotide",
    "Status": "Under Development",
    "Approach": "Exon inclusion",
    "Indication ": "Brain/Spinal cord",
    "IND available?": "No",
    "Variant Publication": "https://pubmed.ncbi.nlm.nih.gov/9792409/",
    "Cell Line or Animal Model Availability": "Yes, cell line"
  },
  {
    "ID": 18,
    "Current Date": "04.03.2024",
    "Display in Registry": "Yes",
    "Gene": "ATM",
    "RefSeq Transcript": "NM_000051.4",
    "Coding DNA change (c.)": "c.3576G>A\r\n",
    "Predicted protein change (p.)": "p.Lys1192=",
    "Confirmed protein or RNA change (for splicing variants)": "r.3403_3576del, p.Ser1135_Lys1192del",
    "Variant published?": "Yes",
    "Contact Person": "Synofzik Lab",
    "Institution": "Tuebingen",
    "Contact Information (email)": "matthis.synofzik@uni-tuebingen.de",
    "Therapeutic Modality": "Antisense oligonucleotide",
    "Status": "Under Development",
    "Approach": "Exon inclusion",
    "Indication ": "Brain/Spinal cord",
    "IND available?": "No",
    "Variant Publication": "https://pubmed.ncbi.nlm.nih.gov/9887333/",
    "Cell Line or Animal Model Availability": "Yes, cell line"
  },
  {
    "ID": 19,
    "Current Date": "04.03.2024",
    "Display in Registry": "Yes",
    "Gene": "ATM",
    "RefSeq Transcript": "NM_000051.4",
    "Coding DNA change (c.)": "c.7788G>A\r\n",
    "Predicted protein change (p.)": "p.Glu2596=",
    "Confirmed protein or RNA change (for splicing variants)": "r.7630_7788del, p.Leu2544_Glu2596del",
    "Variant published?": "Yes",
    "Contact Person": "Synofzik Lab",
    "Institution": "Tuebingen",
    "Contact Information (email)": "matthis.synofzik@uni-tuebingen.de",
    "Therapeutic Modality": "Antisense oligonucleotide",
    "Status": "Under Development",
    "Approach": "Exon inclusion",
    "Indication ": "Brain/Spinal cord",
    "IND available?": "No",
    "Variant Publication": "https://pubmed.ncbi.nlm.nih.gov/9792409/",
    "Cell Line or Animal Model Availability": "Yes, cell line"
  },
  {
    "ID": 20,
    "Current Date": "04.22.2024",
    "Display in Registry": "Yes",
    "Gene": "ABCA4",
    "RefSeq Transcript": "NM_000350.3",
    "Coding DNA change (c.)": "c.859-506G>C",
    "Predicted protein change (p.)": "p.?",
    "Confirmed protein or RNA change (for splicing variants)": "Pseudoexon activation;\r\n\r\nr.858_859ins[56], p.Phe287Thrfs*32",
    "Variant published?": "Yes",
    "Contact Person": "DCRT - Collin Lab",
    "Institution": "Nijmegen",
    "Contact Information (email)": "rob.collin@radboudumc.nl",
    "Therapeutic Modality": "Antisense oligonucleotide",
    "Status": "Under Development",
    "Approach": "Splice correction",
    "Indication ": "Eye",
    "IND available?": "No",
    "Therapy Publication": "https://pubmed.ncbi.nlm.nih.gov/30643219/",
    "Variant Publication": "https://pubmed.ncbi.nlm.nih.gov/30643219/"
  },
  {
    "ID": 21,
    "Current Date": "04.22.2024",
    "Display in Registry": "Yes",
    "Gene": "ABCA4",
    "RefSeq Transcript": "NM_000350.3",
    "Coding DNA change (c.)": "c.6817-713A>G",
    "Predicted protein change (p.)": "p.?",
    "Confirmed protein or RNA change (for splicing variants)": "Pseudoexon activation;\r\n\r\nr.6730_6816ins[6817-835_6817-714], p.Gln2272_Asp2273ins*11",
    "Variant published?": "Yes",
    "Contact Person": "DCRT - Collin Lab",
    "Institution": "Nijmegen",
    "Contact Information (email)": "rob.collin@radboudumc.nl",
    "Therapeutic Modality": "Antisense oligonucleotide",
    "Status": "Under Development",
    "Approach": "Splice correction",
    "Indication ": "Eye",
    "IND available?": "No",
    "Therapy Publication": "https://pubmed.ncbi.nlm.nih.gov/38607040/",
    "Variant Publication": "https://pubmed.ncbi.nlm.nih.gov/38607040/"
  },
  {
    "ID": 22,
    "Current Date": "04.15.2024",
    "Display in Registry": "Yes",
    "Gene": "ACTL6B",
    "RefSeq Transcript": "NM_016188.5",
    "Coding DNA change (c.)": "c.1027G>A ",
    "Predicted protein change (p.)": "p.Gly343Arg",
    "Variant published?": "Yes",
    "Contact Person": "DCRT ",
    "Institution": "Leiden",
    "Contact Information (email)": "dcrt@lumc.nl",
    "Therapeutic Modality": "Antisense oligonucleotide",
    "Status": "Under Development",
    "Approach": "Knockdown",
    "Indication ": "Brain/Spinal cord",
    "IND available?": "No",
    "Variant Publication": "https://pubmed.ncbi.nlm.nih.gov/31031012/"
  },
  {
    "ID": 23,
    "Current Date": "04.15.2024",
    "Display in Registry": "Yes",
    "Gene": "NDUFAF6",
    "RefSeq Transcript": "NM_152416.4",
    "Coding DNA change (c.)": "c.420+784C>T",
    "Predicted protein change (p.)": "p.?",
    "Confirmed protein or RNA change (for splicing variants)": "shifted alternative splicing leading to increased generation of noncoding transcript",
    "Variant published?": "Yes",
    "Contact Person": "DCRT ",
    "Institution": "Leiden",
    "Contact Information (email)": "dcrt@lumc.nl",
    "Therapeutic Modality": "Antisense oligonucleotide",
    "Status": "Under Development",
    "Approach": "Splice correction",
    "Indication ": "Brain/Spinal cord",
    "IND available?": "No",
    "Variant Publication": "https://pubmed.ncbi.nlm.nih.gov/29531337/",
    "Cell Line or Animal Model Availability": "Yes, cell line"
  },
  {
    "ID": 24,
    "Current Date": "04.15.2024",
    "Display in Registry": "Yes",
    "Gene": "ANKRD17",
    "RefSeq Transcript": "NM_032217.5",
    "Coding DNA change (c.)": "Exon 9",
    "Contact Person": "DCRT ",
    "Institution": "Leiden",
    "Contact Information (email)": "dcrt@lumc.nl",
    "Therapeutic Modality": "Antisense oligonucleotide",
    "Status": "Under Development",
    "Approach": "Exon Skipping",
    "Indication ": "Brain/Spinal cord",
    "IND available?": "No",
    "Cell Line or Animal Model Availability": "No"
  },
  {
    "ID": 25,
    "Current Date": "04.15.2024",
    "Display in Registry": "Yes",
    "Gene": "ANKRD17",
    "RefSeq Transcript": "NM_032217.5",
    "Coding DNA change (c.)": "Exon 13",
    "Contact Person": "DCRT ",
    "Institution": "Leiden",
    "Contact Information (email)": "dcrt@lumc.nl",
    "Therapeutic Modality": "Antisense oligonucleotide",
    "Status": "Under Development",
    "Approach": "Exon Skipping",
    "Indication ": "Brain/Spinal cord",
    "IND available?": "No",
    "Cell Line or Animal Model Availability": "No"
  },
  {
    "ID": 26,
    "Current Date": "04.15.2024",
    "Display in Registry": "Yes",
    "Gene": "CHD2",
    "RefSeq Transcript": "NM_001271.4",
    "Coding DNA change (c.)": "c.3021dup",
    "Predicted protein change (p.)": "p.Glu1008*",
    "Contact Person": "DCRT ",
    "Institution": "Leiden",
    "Contact Information (email)": "dcrt@lumc.nl",
    "Therapeutic Modality": "Antisense oligonucleotide",
    "Status": "Under Development",
    "Approach": "Exon Skipping",
    "Indication ": "Brain/Spinal cord",
    "IND available?": "No",
    "Cell Line or Animal Model Availability": "No"
  },
  {
    "ID": 27,
    "Current Date": "04.15.2024",
    "Display in Registry": "Yes",
    "Gene": "PLP1",
    "RefSeq Transcript": "NM_000533.5",
    "Coding DNA change (c.)": "c.453+159G>A ",
    "Predicted protein change (p.)": "p.?",
    "Confirmed protein or RNA change (for splicing variants)": "shifted PLP1/DM20 alternative splicing",
    "Variant published?": "Yes",
    "Contact Person": "DCRT ",
    "Institution": "Leiden",
    "Contact Information (email)": "dcrt@lumc.nl",
    "Therapeutic Modality": "Antisense oligonucleotide",
    "Status": "Under Development",
    "Approach": "Exon inclusion",
    "Indication ": "Brain/Spinal cord",
    "IND available?": "No",
    "Therapy Publication": "https://pubmed.ncbi.nlm.nih.gov/30195779/",
    "Variant Publication": "https://pubmed.ncbi.nlm.nih.gov/26125040/",
    "Cell Line or Animal Model Availability": "Yes, cell line"
  },
  {
    "ID": 28,
    "Current Date": "04.15.2024",
    "Display in Registry": "Yes",
    "Gene": "PLP1",
    "RefSeq Transcript": "NM_000533.5",
    "Coding DNA change (c.)": "c.454-312C>G",
    "Predicted protein change (p.)": "p.?",
    "Confirmed protein or RNA change (for splicing variants)": "shifted PLP1/DM20 alternative splicing",
    "Variant published?": "Yes",
    "Contact Person": "DCRT ",
    "Institution": "Leiden",
    "Contact Information (email)": "dcrt@lumc.nl",
    "Therapeutic Modality": "Antisense oligonucleotide",
    "Status": "Under Development",
    "Approach": "Exon inclusion",
    "Indication ": "Brain/Spinal cord",
    "IND available?": "No",
    "Therapy Publication": "https://pubmed.ncbi.nlm.nih.gov/30195779/",
    "Variant Publication": "https://pubmed.ncbi.nlm.nih.gov/26125040/",
    "Cell Line or Animal Model Availability": "Yes, cell line"
  },
  {
    "ID": 29,
    "Current Date": "12.21.2024",
    "Display in Registry": "Yes",
    "Gene": "PLP1",
    "RefSeq Transcript": "NM_000533.5",
    "Coding DNA change (c.)": "c.441A>T",
    "Predicted protein change (p.)": "p.Gly147= ",
    "Confirmed protein or RNA change (for splicing variants)": "shifted PLP1/DM20 alternative splicing",
    "Variant published?": "Yes",
    "Contact Person": "DCRT ",
    "Institution": "Leiden",
    "Contact Information (email)": "dcrt@lumc.nl",
    "Therapeutic Modality": "Antisense oligonucleotide",
    "Status": "Under Development",
    "Approach": "Exon inclusion",
    "Indication ": "Brain/Spinal cord",
    "IND available?": "No",
    "Therapy Publication": "https://pubmed.ncbi.nlm.nih.gov/30195779/",
    "Variant Publication": "https://pubmed.ncbi.nlm.nih.gov/26125040/",
    "Cell Line or Animal Model Availability": "Yes, cell line"
  },
  {
    "ID": 30,
    "Current Date": "12.21.2024",
    "Display in Registry": "Yes",
    "Gene": "PLP1",
    "RefSeq Transcript": "NM_000533.5",
    "Coding DNA change (c.)": "c.453+28_453+46del",
    "Predicted protein change (p.)": "p.?",
    "Confirmed protein or RNA change (for splicing variants)": "shifted PLP1/DM20 alternative splicing",
    "Variant published?": "Yes",
    "Contact Person": "DCRT ",
    "Institution": "Leiden",
    "Contact Information (email)": "dcrt@lumc.nl",
    "Therapeutic Modality": "Antisense oligonucleotide",
    "Status": "Under Development",
    "Approach": "Exon inclusion",
    "Indication ": "Brain/Spinal cord",
    "IND available?": "No",
    "Therapy Publication": "https://pubmed.ncbi.nlm.nih.gov/30195779/",
    "Variant Publication": "https://pubmed.ncbi.nlm.nih.gov/12325077/",
    "Cell Line or Animal Model Availability": "Yes, cell line"
  },
  {
    "ID": 31,
    "Current Date": "12.21.2024",
    "Display in Registry": "Yes",
    "Gene": "PLP1",
    "RefSeq Transcript": "NM_000533.5",
    "Coding DNA change (c.)": "c.347C>A",
    "Predicted protein change (p.)": "p.Thr116Lys",
    "Confirmed protein or RNA change (for splicing variants)": "shifted PLP1/DM20 alternative splicing",
    "Variant published?": "Yes",
    "Contact Person": "DCRT ",
    "Institution": "Leiden",
    "Contact Information (email)": "dcrt@lumc.nl",
    "Therapeutic Modality": "Antisense oligonucleotide",
    "Status": "Under Development",
    "Approach": "Exon inclusion",
    "Indication ": "Brain/Spinal cord",
    "IND available?": "No",
    "Therapy Publication": "https://pubmed.ncbi.nlm.nih.gov/30195779/",
    "Variant Publication": "https://pubmed.ncbi.nlm.nih.gov/30195779/",
    "Cell Line or Animal Model Availability": "Yes, cell line"
  },
  {
    "ID": 32,
    "Current Date": "12.21.2024",
    "Display in Registry": "Yes",
    "Gene": "PLP1",
    "RefSeq Transcript": "NM_000533.5",
    "Coding DNA change (c.)": "c.453+7A>G",
    "Predicted protein change (p.)": "p.?",
    "Confirmed protein or RNA change (for splicing variants)": "shifted PLP1/DM20 alternative splicing",
    "Variant published?": "Yes",
    "Contact Person": "DCRT ",
    "Institution": "Leiden",
    "Contact Information (email)": "dcrt@lumc.nl",
    "Therapeutic Modality": "Antisense oligonucleotide",
    "Status": "Under Development",
    "Approach": "Exon inclusion",
    "Indication ": "Brain/Spinal cord",
    "IND available?": "No",
    "Therapy Publication": "https://pubmed.ncbi.nlm.nih.gov/30195779/",
    "Variant Publication": "https://pubmed.ncbi.nlm.nih.gov/26125040/",
    "Cell Line or Animal Model Availability": "Yes, cell line"
  },
  {
    "ID": 33,
    "Current Date": "12.21.2024",
    "Display in Registry": "Yes",
    "Gene": "FAR1",
    "RefSeq Transcript": "NM_032228.6",
    "Coding DNA change (c.)": "c.1438C>T ",
    "Predicted protein change (p.)": "p.Arg480Cys",
    "Variant published?": "Yes",
    "Contact Person": "DCRT ",
    "Institution": "Leiden",
    "Contact Information (email)": "dcrt@lumc.nl",
    "Therapeutic Modality": "Antisense oligonucleotide",
    "Status": "Under Development",
    "Approach": "Knockdown",
    "Indication ": "Brain/Spinal cord",
    "IND available?": "No",
    "Variant Publication": "https://pubmed.ncbi.nlm.nih.gov/33239752/",
    "Cell Line or Animal Model Availability": "Yes, cell line"
  },
  {
    "ID": 34,
    "Current Date": "12.21.2024",
    "Display in Registry": "Yes",
    "Gene": "FAR1",
    "RefSeq Transcript": "NM_032228.6",
    "Coding DNA change (c.)": "c.1439G>A ",
    "Predicted protein change (p.)": "p.Arg480His",
    "Variant published?": "Yes",
    "Contact Person": "DCRT ",
    "Institution": "Leiden",
    "Contact Information (email)": "dcrt@lumc.nl",
    "Therapeutic Modality": "Antisense oligonucleotide",
    "Status": "Under Development",
    "Approach": "Knockdown",
    "Indication ": "Brain/Spinal cord",
    "IND available?": "No",
    "Variant Publication": "https://pubmed.ncbi.nlm.nih.gov/33239752/",
    "Cell Line or Animal Model Availability": "Yes, cell line"
  },
  {
    "ID": 35,
    "Current Date": "07.16.2024",
    "Display in Registry": "Yes",
    "Gene": "COL6A1",
    "RefSeq Transcript": "NM_001848.3",
    "Coding DNA change (c.)": "c.930+189C>T",
    "Predicted protein change (p.)": "p.?",
    "Confirmed protein or RNA change (for splicing variants)": "Pseudoexon activation;\r\n\r\nr.930_931ins[930+116_930+187],\r\np.Lys310_Gly311insX[24]",
    "Variant published?": "Yes",
    "Contact Person": "UPNAT - Zhou Lab",
    "Institution": "UCL",
    "Contact Information (email)": "haiyan.zhou@ucl.ac.uk",
    "Therapeutic Modality": "Antisense oligonucleotide",
    "Status": "Developed",
    "Approach": "Exon Skipping",
    "Indication ": "Muscular",
    "IND available?": "No",
    "Therapy Publication": "https://pubmed.ncbi.nlm.nih.gov/32585628/",
    "Variant Publication": "https://pubmed.ncbi.nlm.nih.gov/30895940/",
    "Cell Line or Animal Model Availability": "Yes, cell line"
  },
  {
    "ID": 36,
    "Current Date": "07.16.2024",
    "Display in Registry": "Yes",
    "Gene": "COL6A3",
    "RefSeq Transcript": "NM_004369.4",
    "Coding DNA change (c.)": "c.6210+1G>A",
    "Predicted protein change (p.)": "p.?",
    "Confirmed protein or RNA change (for splicing variants)": "Exon skipping;\r\n\r\nr.6157_6210del, p.Ile2054_Gly2071del",
    "Variant published?": "Yes",
    "Contact Person": "UPNAT - Zhou Lab",
    "Institution": "UCL",
    "Contact Information (email)": "haiyan.zhou@ucl.ac.uk",
    "Therapeutic Modality": "Antisense oligonucleotide",
    "Status": "Under Development",
    "Approach": "Knockdown",
    "Indication ": "Muscular",
    "IND available?": "No",
    "Therapy Publication": "https://pubmed.ncbi.nlm.nih.gov/38993932/",
    "Variant Publication": "https://pubmed.ncbi.nlm.nih.gov/18366090/",
    "Cell Line or Animal Model Availability": "Yes, cell line"
  },
  {
    "ID": 37,
    "Current Date": "07.16.2024",
    "Display in Registry": "Yes",
    "Gene": "COL6A3",
    "RefSeq Transcript": "NM_004369.4",
    "Coding DNA change (c.)": "c.6135_6152del",
    "Predicted protein change (p.)": "p.Ile2046_Pro2051del",
    "Variant published?": "Yes",
    "Contact Person": "UPNAT - Zhou Lab",
    "Institution": "UCL",
    "Contact Information (email)": "haiyan.zhou@ucl.ac.uk",
    "Therapeutic Modality": "Antisense oligonucleotide",
    "Status": "Under Development",
    "Approach": "Knockdown",
    "Indication ": "Muscular",
    "IND available?": "No",
    "Therapy Publication": "https://pubmed.ncbi.nlm.nih.gov/28918041/",
    "Variant Publication": "https://pubmed.ncbi.nlm.nih.gov/28918041/",
    "Cell Line or Animal Model Availability": "Yes, cell line"
  },
  {
    "ID": 38,
    "Current Date": "07.16.2024",
    "Display in Registry": "Yes",
    "Gene": "SPTLC1",
    "RefSeq Transcript": "NM_006415.4",
    "Coding DNA change (c.)": "c.399T>G",
    "Predicted protein change (p.)": "p.Cys133Trp",
    "Variant published?": "Yes",
    "Contact Person": "UPNAT - Zhou Lab",
    "Institution": "UCL",
    "Contact Information (email)": "haiyan.zhou@ucl.ac.uk",
    "Therapeutic Modality": "Antisense oligonucleotide",
    "Status": "Under Development",
    "Approach": "Knockdown",
    "Indication ": "Brain/Spinal cord",
    "IND available?": "No",
    "Variant Publication": "https://pubmed.ncbi.nlm.nih.gov/16210380/",
    "Cell Line or Animal Model Availability": "Yes, cell line"
  },
  {
    "ID": 39,
    "Current Date": "6.2.2025",
    "Display in Registry": "Yes",
    "Gene": "MFSD8",
    "RefSeq Transcript": "NM_001371596.2",
    "Coding DNA change (c.)": "c.554-847_554-846insSVA",
    "Predicted protein change (p.)": "p.?",
    "Confirmed protein or RNA change (for splicing variants)": "Creation of a cryptic splice acceptor in exon 6 leading to premature termination codon",
    "Variant published?": "Yes",
    "Contact Person": "Yu Lab",
    "Institution": "BCH",
    "Contact Information (email)": "Tyuresearch@childrens.harvard.edu",
    "Therapeutic Modality": "Antisense oligonucleotide",
    "Status": "Clinical Application",
    "Approach": "Splice correction",
    "Indication ": "Brain/Spinal cord",
    "IND available?": "Yes",
    "Information on IND": "POC and tox study is able to be shared, if the receiving entity has signed the preclinical DSA with N1C",
    "Therapy Publication": "https://pubmed.ncbi.nlm.nih.gov/31597037/",
    "Cell Line or Animal Model Availability": "Yes, cell line"
  },
  {
    "ID": 40,
    "Current Date": "05.25.2025",
    "Display in Registry": "Yes",
    "Gene": "C9orf72",
    "Variant published?": "Unknown",
    "Contact Person": "Jon Watts",
    "Institution": "UMass Chan",
    "Contact Information (email)": "jonathan.watts@umassmed.edu",
    "Therapeutic Modality": "Antisense oligonucleotide",
    "Status": "Clinical Application",
    "Approach": "Knockdown",
    "Indication ": "Brain/Spinal cord",
    "IND available?": "Unknown",
    "Therapy Publication": "https://pubmed.ncbi.nlm.nih.gov/34949835/",
    "Comment": "C9orf72-targeting ASOs have failed in clinical trials to this date (May 2025)."
  },
  {
    "ID": 41,
    "Current Date": "05.25.2025",
    "Display in Registry": "Yes",
    "Gene": "CLN3",
    "RefSeq Transcript": "NM_001042432.2",
    "Coding DNA change (c.)": "c.569dup",
    "Predicted protein change (p.)": "p.Ala191Serfs*45 ",
    "Variant published?": "Yes",
    "Contact Person": "Michelle Hastings",
    "Institution": "University of North Carolina Chapel Hill, University of Michigan, ForeBatten Foundation",
    "Contact Information (email)": "hastingm@umich.edu",
    "Therapeutic Modality": "Antisense oligonucleotide",
    "Status": "Clinical Application",
    "Approach": "Exon Skipping",
    "Indication ": "Brain/Spinal cord",
    "IND available?": "No",
    "Therapy Publication": "https://www.forebatten.org/zebronkysen"
  },
  {
    "ID": 42,
    "Current Date": "05.25.2025",
    "Display in Registry": "Yes",
    "Gene": "FUS",
    "RefSeq Transcript": "NM_004960.4",
    "Coding DNA change (c.)": "c.1574C>T",
    "Predicted protein change (p.)": "p.Pro525Leu",
    "Variant published?": "Yes",
    "Contact Person": "Neil Shneider",
    "Institution": "Columbia, Ionis",
    "Contact Information (email)": "ns327@cumc.columbia.edu",
    "Therapeutic Modality": "Antisense oligonucleotide",
    "Status": "Clinical Application",
    "Approach": "Knockdown",
    "Indication ": "Brain/Spinal cord",
    "IND available?": "Unknown",
    "Therapy Publication": "https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)00513-6/fulltext"
  },
  {
    "ID": 43,
    "Current Date": "05.25.2025",
    "Display in Registry": "Yes",
    "Gene": "TNPO2",
    "RefSeq Transcript": "NM_001382241.1",
    "Coding DNA change (c.)": "c.466G>A",
    "Predicted protein change (p.)": "p.Asp156Asn",
    "Variant published?": "Yes",
    "Contact Person": "TNPO2 Foundation",
    "Institution": "TNPO2 Foundation",
    "Contact Information (email)": "https://www.tnpo2.org/",
    "Therapeutic Modality": "Antisense oligonucleotide",
    "Status": "Clinical Application",
    "Approach": "Knockdown (allele-selective)",
    "Indication ": "Brain/Spinal cord",
    "IND available?": "Yes",
    "Information on IND": "https://www.tnpo2.org/ind-documents",
    "Cell Line or Animal Model Availability": "Yes, cell line",
    "Comment": "ASO targets the variant"
  },
  {
    "ID": 44,
    "Current Date": "05.25.2025",
    "Display in Registry": "Yes",
    "Gene": "AP4M1 (SPG50)",
    "RefSeq Transcript": "NM_004722.4",
    "Variant published?": "Yes",
    "Contact Person": "SickKids",
    "Institution": "SickKids",
    "Contact Information (email)": "SickKids Toronto",
    "Therapeutic Modality": "Gene replacement",
    "Status": "Clinical Application",
    "Indication ": "Brain/Spinal cord",
    "IND available?": "Yes",
    "Information on IND": "https://www.elpidatx.com/documents",
    "Therapy Publication": "https://pubmed.ncbi.nlm.nih.gov/38942994/"
  },
  {
    "ID": 45,
    "Current Date": "05.25.2025",
    "Display in Registry": "Yes",
    "Gene": "CPS1",
    "RefSeq Transcript": "NM_001875.5",
    "Coding DNA change (c.)": "c.1003C>T",
    "Predicted protein change (p.)": "p.Gln335*",
    "Variant published?": "Yes",
    "Contact Person": "Rebecca Ahrens-Nicklas",
    "Institution": "Children’s Hospital of Philadelphia",
    "Contact Information (email)": "ahrensnicklasr@chop.edu",
    "Therapeutic Modality": "Gene editing",
    "Status": "Clinical Application",
    "Indication ": "Liver",
    "IND available?": "Unknown",
    "Therapy Publication": "https://www.nejm.org/doi/full/10.1056/NEJMoa2504747"
  },
  {
    "ID": 46,
    "Current Date": "06.02.2025",
    "Display in Registry": "Yes",
    "Gene": "MFSD8",
    "RefSeq Transcript": "NM_152778.4",
    "Coding DNA change (c.)": "c.999G>A",
    "Predicted protein change (p.)": "p.Lys333=",
    "Confirmed protein or RNA change (for splicing variants)": "Exon skipping;\r\n\r\nr.999_1102del, p.Ile334Phefs*4",
    "Variant published?": "Yes",
    "Contact Person": "Yu Lab",
    "Institution": "BCH",
    "Contact Information (email)": "Tyuresearch@childrens.harvard.edu",
    "Therapeutic Modality": "Antisense oligonucleotide",
    "Status": "Currently Not Pursued for Development",
    "Approach": "Splice correction",
    "Indication ": "Brain/Spinal cord",
    "IND available?": "No",
    "Variant Publication": "https://pubmed.ncbi.nlm.nih.gov/28794409/",
    "Cell Line or Animal Model Availability": "Yes, cell line"
  },
  {
    "ID": 47,
    "Current Date": "06.02.2025",
    "Display in Registry": "Yes",
    "Gene": "NPC1",
    "RefSeq Transcript": "NM_000271.5",
    "Coding DNA change (c.)": "c.1554-1009G>A",
    "Predicted protein change (p.)": "p.?",
    "Confirmed protein or RNA change (for splicing variants)": "Pseudoexon activation;\r\n\r\nr.?",
    "Variant published?": "Yes",
    "Contact Person": "Yu Lab",
    "Institution": "BCH",
    "Contact Information (email)": "Tyuresearch@childrens.harvard.edu",
    "Therapeutic Modality": "Antisense oligonucleotide",
    "Status": "Under Development",
    "Approach": "Splice correction",
    "Indication ": "Brain/Spinal cord",
    "IND available?": "No",
    "Variant Publication": "https://pubmed.ncbi.nlm.nih.gov/20718790/",
    "Cell Line or Animal Model Availability": "Yes, cell line"
  },
  {
    "ID": 48,
    "Current Date": "06.02.2025",
    "Display in Registry": "Yes",
    "Gene": "DNAJC5",
    "RefSeq Transcript": "NM_025219.3",
    "Coding DNA change (c.)": "c.344T>G",
    "Predicted protein change (p.)": "p.Leu115Arg",
    "Variant published?": "Yes",
    "Contact Person": "Yu Lab",
    "Institution": "BCH",
    "Contact Information (email)": "Tyuresearch@childrens.harvard.edu",
    "Therapeutic Modality": "Antisense oligonucleotide",
    "Status": "Under Development",
    "Approach": "Knockdown (allele-selective)",
    "Indication ": "Brain/Spinal cord",
    "IND available?": "No",
    "Variant Publication": "https://pubmed.ncbi.nlm.nih.gov/22235333/",
    "Cell Line or Animal Model Availability": "Yes, cell line"
  },
  {
    "ID": 49,
    "Current Date": "06.02.2025",
    "Display in Registry": "Yes",
    "Gene": "NDUFAF8",
    "RefSeq Transcript": "NM_001086521.2",
    "Coding DNA change (c.)": "c.195+271C>T",
    "Predicted protein change (p.)": "p?",
    "Confirmed protein or RNA change (for splicing variants)": "r.?",
    "Variant published?": "Yes",
    "Contact Person": "Yu Lab",
    "Institution": "BCH",
    "Contact Information (email)": "Tyuresearch@childrens.harvard.edu",
    "Therapeutic Modality": "Antisense oligonucleotide",
    "Status": "Under Development",
    "Approach": "Knockdown (allele-selective)",
    "Indication ": "Brain/Spinal cord",
    "IND available?": "No",
    "Variant Publication": "https://pubmed.ncbi.nlm.nih.gov/31866046/",
    "Cell Line or Animal Model Availability": "Yes, cell line"
  },
  {
    "ID": 50,
    "Current Date": "06.02.2025",
    "Display in Registry": "Yes",
    "Gene": "ABCA4",
    "RefSeq Transcript": "NM_000350.3",
    "Coding DNA change (c.)": "c.5461-10T>C",
    "Predicted protein change (p.)": "p?",
    "Confirmed protein or RNA change (for splicing variants)": "Exon skipping;\r\n\r\nExon 39 (p.Thr1821Aspfs*6);\r\nExons 39-40 (p.Thr1821Valfs*13)",
    "Variant published?": "Yes",
    "Contact Person": "Yu Lab",
    "Institution": "BCH",
    "Contact Information (email)": "Tyuresearch@childrens.harvard.edu",
    "Therapeutic Modality": "Antisense oligonucleotide",
    "Status": "Under Development",
    "Approach": "Splice correction",
    "Indication ": "Eye",
    "IND available?": "No",
    "Variant Publication": "https://pubmed.ncbi.nlm.nih.gov/36910710/",
    "Cell Line or Animal Model Availability": "Yes, cell line"
  },
  {
    "ID": 51,
    "Current Date": "05.25.2025",
    "Display in Registry": "Yes",
    "Gene": "FUS",
    "RefSeq Transcript": "NM_004960.4",
    "Coding DNA change (c.)": "c.1562G>T",
    "Predicted protein change (p.)": "p.Arg521Leu",
    "Variant published?": "Yes",
    "Contact Person": "Neil Shneider",
    "Institution": "Columbia, Ionis",
    "Contact Information (email)": "ns327@cumc.columbia.edu",
    "Therapeutic Modality": "Antisense oligonucleotide",
    "Status": "Clinical Application",
    "Approach": "Knockdown",
    "Indication ": "Brain/Spinal cord",
    "IND available?": "Unknown",
    "Therapy Publication": "https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)00513-6/fulltext",
    "Variant Publication": "https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)00513-6/fulltext"
  },
  {
    "ID": 52,
    "Current Date": "05.25.2025",
    "Display in Registry": "Yes",
    "Gene": "FUS",
    "RefSeq Transcript": "NM_004960.4",
    "Coding DNA change (c.)": "c.1545_1547dup",
    "Predicted protein change (p.)": "p.Gly515_Glu516insAsp",
    "Variant published?": "Yes",
    "Contact Person": "Neil Shneider",
    "Institution": "Columbia, Ionis",
    "Contact Information (email)": "ns327@cumc.columbia.edu",
    "Therapeutic Modality": "Antisense oligonucleotide",
    "Status": "Clinical Application",
    "Approach": "Knockdown",
    "Indication ": "Brain/Spinal cord",
    "IND available?": "Unknown",
    "Therapy Publication": "https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)00513-6/fulltext",
    "Variant Publication": "https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)00513-6/fulltext"
  },
  {
    "ID": 53,
    "Current Date": "05.25.2025",
    "Display in Registry": "Yes",
    "Gene": "FUS",
    "RefSeq Transcript": "NM_004960.4",
    "Coding DNA change (c.)": "c.571G>A",
    "Predicted protein change (p.)": "p.Gly191Ser",
    "Variant published?": "Yes",
    "Contact Person": "Neil Shneider",
    "Institution": "Columbia, Ionis",
    "Contact Information (email)": "ns327@cumc.columbia.edu",
    "Therapeutic Modality": "Antisense oligonucleotide",
    "Status": "Clinical Application",
    "Approach": "Knockdown",
    "Indication ": "Brain/Spinal cord",
    "IND available?": "Unknown",
    "Therapy Publication": "https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)00513-6/fulltext",
    "Variant Publication": "https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)00513-6/fulltext"
  },
  {
    "ID": 54,
    "Current Date": "05.25.2025",
    "Display in Registry": "Yes",
    "Gene": "FUS",
    "RefSeq Transcript": "NM_004960.4",
    "Coding DNA change (c.)": "c.1561C>G",
    "Predicted protein change (p.)": "p.Arg521Gly",
    "Variant published?": "Yes",
    "Contact Person": "Neil Shneider",
    "Institution": "Columbia, Ionis",
    "Contact Information (email)": "ns327@cumc.columbia.edu",
    "Therapeutic Modality": "Antisense oligonucleotide",
    "Status": "Clinical Application",
    "Approach": "Knockdown",
    "Indication ": "Brain/Spinal cord",
    "IND available?": "Unknown",
    "Therapy Publication": "https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)00513-6/fulltext",
    "Variant Publication": "https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)00513-6/fulltext"
  },
  {
    "ID": 71,
    "Current Date": "20.06.2025",
    "Display in Registry": "Yes",
    "Gene": "ATM",
    "RefSeq Transcript": "NM_000051.4",
    "Coding DNA change (c.)": "c.1564_1565del",
    "Predicted protein change (p.)": "p.Glu522Ilefs*43",
    "Variant published?": "Yes",
    "Contact Person": "Synofzik Lab",
    "Institution": "Tuebingen",
    "Contact Information (email)": "matthis.synofzik@uni-tuebingen.de",
    "Therapeutic Modality": "Antisense oligonucleotide",
    "Status": "Under Development",
    "Approach": "Exon Skipping",
    "Indication ": "Brain/Spinal cord",
    "IND available?": "No",
    "Variant Publication": "https://pubmed.ncbi.nlm.nih.gov/39067332/",
    "Cell Line or Animal Model Availability": "Yes, cell line"
  },
  {
    "ID": 73,
    "Current Date": "7.7.2025",
    "Display in Registry": "Yes",
    "Gene": "LMNA",
    "RefSeq Transcript": "NM_170707.4",
    "Coding DNA change (c.)": "c.1824C>T",
    "Predicted protein change (p.)": "p.Gly608=",
    "Confirmed protein or RNA change (for splicing variants)": "Partial exon deletion;\r\nr.1819_1968del, p.Vall607_Gln656del",
    "Variant published?": "Yes",
    "Contact Person": "Barbara Natke",
    "Institution": "The Progeria Research Foundation",
    "Contact Information (email)": "bnatke@progeriaresearch.org",
    "Therapeutic Modality": "Gene editing",
    "Status": "Under Development",
    "Cell Line or Animal Model Availability": "Yes, cell line",
    "Comment": "2 models are available:  G608G and G609G "
  },
  {
    "ID": 74,
    "Current Date": "7.7.2025",
    "Display in Registry": "Yes",
    "Gene": "COL7A1",
    "RefSeq Transcript": "NM_000094.4",
    "Coding DNA change (c.)": "c.6805G>A",
    "Predicted protein change (p.)": "p.Gly2269Arg",
    "Variant published?": "No",
    "Contact Person": "May Aung-Htut & Steve Wilton, Kristin Ham",
    "Institution": "Personalised Medicine Centre, Murdoch University",
    "Contact Information (email)": "kristin.ham@murdoch.edu.au",
    "Therapeutic Modality": "Antisense oligonucleotide",
    "Status": "Under Development",
    "Approach": "Exon Skipping",
    "Cell Line or Animal Model Availability": "Yes, cell line"
  }
]